Company Snapshot
Valeant Pharmaceuticals International, Inc.: Key Employees
Valeant Pharmaceuticals International, Inc.: Major Products and Services
Valeant Pharmaceuticals International, Inc.: Company History
Valeant Pharmaceuticals International, Inc.: Key Competitors
Valeant Pharmaceuticals International, Inc.: Company Analysis
Valeant Pharmaceuticals International, Inc.: Business Description
Valeant Pharmaceuticals International, Inc.: Corporate Financial Deals Activity
Valeant Pharmaceuticals International, Inc.: Financial Deals Overview
Valeant Pharmaceuticals International, Inc.: Targets and Partners
Valeant Pharmaceuticals International, Inc.: Top Deals 2007 -YTD*2011
Valeant Pharmaceuticals International, Inc.: Advisors
Valeant Pharmaceuticals International, Inc.: Top Legal Advisors
Valeant Pharmaceuticals International, Inc.: Top Financial Advisors
Valeant Pharmaceuticals International, Inc.: Mergers and Acquisitions
Valeant Pharmaceuticals International, Inc.: Capital Raising
Valeant Pharmaceuticals International, Inc.: Partnership
Valeant Pharmaceuticals International, Inc.: Private Equity and Ownership
Valeant Pharmaceuticals International, Inc.: Recent Developments
Valeant Pharmaceuticals International, Inc.: News and Events Summary
Valeant Pharmaceuticals International, Inc.: Business Expansion
Valeant Pharmaceuticals International, Inc.: Contracts
Valeant Pharmaceuticals International, Inc.: Financial Deals
Valeant Pharmaceuticals International, Inc.: Grants
Appendix
Contact Us
Methodology
Definitions
About Datamonitor
List of Tables
Table 1: Valeant Pharmaceuticals International, Inc.: Key Facts
Table 2: Valeant Pharmaceuticals International, Inc.: Key Employees
Table 3: Valeant Pharmaceuticals International, Inc.: Key Competitors
Table 4: Valeant Pharmaceuticals International, Inc.: Deal Activity by Deal Type - Volume (TTM)
Table 5: Valeant Pharmaceuticals International, Inc.: M&A Activity by Geography (TTM)
Table 6: Valeant Pharmaceuticals International, Inc.: Deal Activity by Deal Type - Volume (2007 - YTD*2011)
Table 7: Valeant Pharmaceuticals International, Inc.: M&A Average Deal Size - Value (US$m)
Table 8: Valeant Pharmaceuticals International, Inc.: Targets and Partners
Table 9: Valeant Pharmaceuticals International, Inc.: Top Deals 2007 -YTD*2011
Table 10: Valeant Pharmaceuticals International, Inc.: Legal Advisor Ranking by Value (US$m)
Table 11: Valeant Pharmaceuticals International, Inc.: Financial Advisor Ranking by Value (US$m)
Table 12: Valeant Pharmaceuticals International, Inc.: M&A Volume and Value Trend (2007 - YTD*2011)
Table 13: Valeant Pharmaceuticals International, Inc.: M&A Activity by Geography (2007 - YTD*2011)
Table 14: Valeant Pharmaceuticals International, Inc.: Capital Raising Volume and Value Trend (2007 - YTD*2011)
Table 15: Valeant Pharmaceuticals International, Inc.: Capital Raising by Deal Type (2007 - YTD*2011)
Table 16: Valeant Pharmaceuticals International, Inc.: Partnership Volume and Value Trend (2007 - YTD*2011)
Table 17: Valeant Pharmaceuticals International, Inc.: Partnership Trend by Deal Type (2007 - YTD*2011)
Table 18: Valeant Pharmaceuticals International, Inc.: Private Equity and Ownership Volume and Value Trend (2007 - YTD*2011)
Table 19: Valeant Pharmaceuticals International, Inc.: Private Equity and Ownership Volume by Deal Type (2007 - YTD*2011)
Table 20: Valeant Pharmaceuticals International, Inc.: News and Events Summary
Table 21: Valeant Pharmaceuticals International, Inc.: Business Expansion
Table 22: Valeant Pharmaceuticals International, Inc.: Contracts
Table 23: Valeant Pharmaceuticals International, Inc.: Financial Deals
Table 24: Valeant Pharmaceuticals International, Inc.: Grants
List of Figures
Figure 1: Valeant Pharmaceuticals International, Inc.: Deal Activity by Deal Type - Volume (TTM)
Figure 2: Valeant Pharmaceuticals International, Inc.: M&A Activity by Geography (TTM)
Figure 3: Valeant Pharmaceuticals International, Inc.: Deal Activity by Deal Type - Volume (2007 - YTD*2011)
Figure 4: Valeant Pharmaceuticals International, Inc.: M&A Average Deal Size - Value (US$m)
Figure 5: Valeant Pharmaceuticals International, Inc.: M&A Volume and Value Trend (2007 - YTD*2011)
Figure 6: Valeant Pharmaceuticals International, Inc.: M&A Activity by Geography (2007 - YTD*2011)
Figure 7: Valeant Pharmaceuticals International, Inc.: Capital Raising Volume and Value Trend (2007 - YTD*2011)
Figure 8: Valeant Pharmaceuticals International, Inc.: Capital Raising by Deal Type (2007 - YTD*2011)
Figure 9: Valeant Pharmaceuticals International, Inc.: Partnership Volume and Value Trend (2007 - YTD*2011)
Figure 10: Valeant Pharmaceuticals International, Inc.: Partnership Trend by Deal Type (2007 - YTD*2011)
Figure 11: Valeant Pharmaceuticals International, Inc.: Private Equity and Ownership Volume and Value Trend (2007 - YTD*2011)
Figure 12: Valeant Pharmaceuticals International, Inc.: Private Equity and Ownership Volume by Deal Type (2007 - YTD*2011)
[Inhaltsverzeichnis ausblenden]